Every Form 4 that Baker Hughes Company (BKR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BKR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BKR filings page.
Baker Hughes Executive Vice President and Chief Financial Officer Moghal Ahmed Farhan reported equity transactions in the company’s Class A Common Stock. On January 26, 2026, 3,843 restricted stock units vested, converting into 3,843 shares of Class A Common Stock, representing the final installment of a grant made on January 24, 2023.
To cover tax obligations, 1,052 of these shares were withheld at a price of $56.29 per share. After these transactions, Farhan directly held 19,145 shares of Class A Common Stock and indirectly held 18,102 shares through his spouse.
Baker Hughes Co (BKR) disclosed a director’s updated equity holdings and compensation-related awards. The director is reported as indirectly owning 18,023 shares of Class A common stock through Cannonbury Investments Limited, with this amount including 153 shares acquired via a dividend reinvestment plan. On December 15, 2025, the director also acquired 3,554.045 Deferred Stock Units, each representing the right to receive one share of Class A common stock. These Deferred Stock Units were fully vested on the grant date and reflect the director’s election to receive 2025 retainer fees in stock, with delivery of the shares deferred until the director ceases to serve on the board.
Baker Hughes Co director reported several equity transactions dated 12/15/2025. The director received 6,377 and 3,932 shares of Class A Common Stock through the settlement of previously granted Restricted Stock Units and Deferred Stock Units, bringing beneficial ownership to 10,309 directly held shares. The director was also credited with 3,447.994 Deferred Stock Units for 2025 retainer fees, which were fully vested on grant and include 26.655 units received as dividend equivalents. Under the Non-Employee Director Deferral Plan, delivery of these deferred shares is postponed until the director ceases to serve on the board.
Baker Hughes director reports deferred stock unit grant tied to 2025 fees. A company director acquired 3,494.922 Deferred Stock Units on December 15, 2025 as part of their 2025 board retainer under the Non-Employee Director Deferral Plan. Each unit represents a right to receive one share of Baker Hughes Class A Common Stock.
The units were fully vested on the grant date, but delivery of the underlying shares will occur when the director ceases to serve on the board. The reported amount includes 27.955 Deferred Stock Units credited as dividend equivalents, and the holding is reported as directly owned by the director.
Baker Hughes Co director equity grant and deferral
A Baker Hughes Co director reported receiving 3,221.396 deferred stock units on December 15, 2025. Each deferred stock unit represents the right to receive one share of Baker Hughes Class A common stock. The reported amount includes 25.513 deferred stock units credited as dividend equivalents.
The units were fully vested on the grant date. Under the company’s Non-Employee Director Deferral Plan, the director elected to take their 2025 board retainer in stock and to delay delivery of the underlying shares until they stop serving as a director.
Baker Hughes (BKR) reported insider activity by its SVP, Controller & CAO. On 11/12/2025, 1,526 restricted stock units vested and converted into Class A shares. To cover taxes the same day, 601 shares were withheld at $47.53. On 11/13/2025, 278 shares were sold at $47.56 pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2025.
Following these transactions, the reporting person directly owned 12,419 Class A shares. The filing also lists 3,053 remaining RSUs. Each RSU represents the right to receive one share, with this tranche representing the first of three equal annual installments vesting from the November 12, 2024 grant date.
Baker Hughes (BKR) disclosed an insider equity transaction on Form 4. On 11/10/2025, the company’s EVP, Chief Financial Officer reported that the reporting person’s spouse exercised stock options, resulting in the acquisition of 5,128 Class A shares (transaction code M).
The option exercises correspond to grants with exercise prices of $22.98, $35.55, and $36.89, totaling 5,128 shares delivered. Following the reported transactions, 18,102 shares were beneficially owned indirectly (by spouse), and 16,354 shares were beneficially owned directly. The options were fully vested and scheduled to expire on 12/31/2025.
James E. Apostolides, Chief Infra & Performance Officer of Baker Hughes Co (BKR), reported transactions on 09/23/2025 under a Rule 10b5-1 plan adopted 11/12/2024. He exercised 6,216 stock options with a $35.55 exercise price and simultaneously sold 6,216 shares at $50. After these transactions he beneficially owned 20,349 Class A shares. The option grant dated 01/22/2018 vested in three equal annual installments beginning one year after grant.
Insider sale by Baker Hughes officer. Rebecca L. Charlton, SVP, Controller & CAO of Baker Hughes Co (BKR), reported a sale of 1,000 shares of Class A common stock on 09/23/2025 at a reported price of $50 per share. After the sale she beneficially owned 11,772 shares of Class A stock. The filing states the sale was made under a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 09/25/2025.
Ramaswamy Sreeganesh, EVP, Industrial & Energy Tech at Baker Hughes (BKR), reported an insider sale. The Form 4 shows a sale of 25,000 shares of Class A common stock on 09/23/2025 at a reported price of $50 per share, reducing his beneficial holdings to 40,520 shares. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted March 5, 2025, and the Form 4 was signed by an attorney-in-fact on 09/25/2025. The report is a single-person filing and lists the reporting person’s Houston address.